Author: Fiorino, Gionata; Allocca, Mariangela; Furfaro, Federica; Gilardi, Daniela; Zilli, Alessandra; Radice, Simona; Spinelli, Antonino; Danese, Silvio
Title: Inflammatory Bowel Disease Care in the COVID-19 Pandemic Era: The Humanitas, Milan, Experience Cord-id: hhd5f823 Document date: 2020_3_24
ID: hhd5f823
Snippet: The outbreak of the COVID-19 caused by coronavirus SARS-CoV2, is rapidly spreading worldwide. This is the first pandemic caused by a coronavirus in history. More than 150 000 confirmed cases worldwide are reported involving the SARS-CoV2, with more than 5000 COVID-19-related deaths on March 14, 2020. Fever, chills, cough, shortness of breath, generalised myalgia, malaise, drowsiness, diarrhoea, confusion, dyspnoea, and bilateral interstitial pneumonia are the common symptoms. No therapies are av
Document: The outbreak of the COVID-19 caused by coronavirus SARS-CoV2, is rapidly spreading worldwide. This is the first pandemic caused by a coronavirus in history. More than 150 000 confirmed cases worldwide are reported involving the SARS-CoV2, with more than 5000 COVID-19-related deaths on March 14, 2020. Fever, chills, cough, shortness of breath, generalised myalgia, malaise, drowsiness, diarrhoea, confusion, dyspnoea, and bilateral interstitial pneumonia are the common symptoms. No therapies are available, and the only way to contain the virus spread is to regularly and thoroughly clean one’s hands with an alcohol-based hand rub or wash them with soap and water, to maintain at least 1 m [3 feet] distance from anyone who is coughing or sneezing, to avoid touching eyes, nose, and mouth, and to stay home if one feels unwell. No data are available on the risk of COVID-19 and outcomes in inflammatory bowel disease [IBD] patients. Outbreak restrictions can impact on the IBD care. We aim to give a viewpoint on how operationally to manage IBD patients and ensure quality of care in the current pandemic era.
Search related documents:
Co phrase search for related documents- active disease and long virus: 1
- active disease and low moderate: 1, 2
- active disease and lung involvement: 1, 2, 3
- active disease and lymphocyte count: 1, 2
- active monitoring and additional information: 1
- active monitoring and additional risk: 1, 2
- additional information and long virus: 1, 2, 3
- additional information and low moderate: 1
- additional information and low moderate risk: 1
- additional information and lung involvement: 1, 2
- additional information and lymphocyte count: 1, 2
- additional risk and low moderate: 1, 2, 3
- additional risk and low moderate risk: 1, 2
- additional risk and lung involvement: 1
- additional risk and lymphocyte count: 1, 2, 3
- long virus and lymphocyte count: 1
- low moderate and lung involvement: 1
- low moderate and lymphocyte count: 1, 2, 3, 4, 5, 6, 7, 8
- low moderate risk and lymphocyte count: 1, 2
Co phrase search for related documents, hyperlinks ordered by date